Insider Selling: Kewaunee Scientific (NASDAQ:KEQU) CEO Sells 2,177 Shares of Stock

by · The Cerbat Gem

Kewaunee Scientific Corporation (NASDAQ:KEQU – Get Free Report) CEO Thomas David Hull III sold 2,177 shares of the company’s stock in a transaction that occurred on Wednesday, January 7th. The shares were sold at an average price of $37.50, for a total value of $81,637.50. Following the completion of the transaction, the chief executive officer owned 33,000 shares in the company, valued at $1,237,500. This represents a 6.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Thomas David Hull III also recently made the following trade(s):

  • On Wednesday, December 31st, Thomas David Hull III sold 629 shares of Kewaunee Scientific stock. The shares were sold at an average price of $37.66, for a total value of $23,688.14.
  • On Tuesday, December 30th, Thomas David Hull III sold 29 shares of Kewaunee Scientific stock. The stock was sold at an average price of $38.00, for a total value of $1,102.00.
  • On Monday, December 29th, Thomas David Hull III sold 884 shares of Kewaunee Scientific stock. The shares were sold at an average price of $38.01, for a total value of $33,600.84.
  • On Monday, December 22nd, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $39.00, for a total value of $39,000.00.

Kewaunee Scientific Stock Performance

Shares of NASDAQ:KEQU traded up $0.01 on Thursday, reaching $37.26. The company’s stock had a trading volume of 909 shares, compared to its average volume of 6,888. The stock’s 50-day moving average is $39.10 and its two-hundred day moving average is $46.95. Kewaunee Scientific Corporation has a 52-week low of $30.33 and a 52-week high of $71.33. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.48 and a quick ratio of 1.71. The stock has a market capitalization of $106.94 million, a P/E ratio of 9.46 and a beta of 0.55.

Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last posted its quarterly earnings results on Wednesday, December 10th. The technology company reported $0.91 earnings per share for the quarter. Kewaunee Scientific had a return on equity of 22.39% and a net margin of 4.11%.The firm had revenue of $70.10 million for the quarter. During the same quarter last year, the firm earned $1.01 earnings per share.

Institutional Trading of Kewaunee Scientific

Institutional investors and hedge funds have recently modified their holdings of the company. First Trust Advisors LP lifted its holdings in shares of Kewaunee Scientific by 3.4% during the second quarter. First Trust Advisors LP now owns 6,726 shares of the technology company’s stock worth $395,000 after buying an additional 222 shares during the last quarter. Geode Capital Management LLC boosted its stake in Kewaunee Scientific by 0.9% in the 2nd quarter. Geode Capital Management LLC now owns 24,013 shares of the technology company’s stock valued at $1,410,000 after buying an additional 223 shares in the last quarter. US Bancorp DE increased its position in shares of Kewaunee Scientific by 80.0% during the 3rd quarter. US Bancorp DE now owns 900 shares of the technology company’s stock worth $38,000 after purchasing an additional 400 shares in the last quarter. Bank of America Corp DE raised its position in Kewaunee Scientific by 2,605.9% in the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock valued at $28,000 after purchasing an additional 443 shares during the last quarter. Finally, Ritholtz Wealth Management lifted its position in Kewaunee Scientific by 6.1% during the 3rd quarter. Ritholtz Wealth Management now owns 13,734 shares of the technology company’s stock worth $586,000 after buying an additional 785 shares in the last quarter. 32.69% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on KEQU. Weiss Ratings reiterated a “hold (c+)” rating on shares of Kewaunee Scientific in a report on Wednesday, October 8th. Wall Street Zen lowered Kewaunee Scientific from a “buy” rating to a “hold” rating in a report on Saturday, December 13th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, Kewaunee Scientific currently has a consensus rating of “Hold”.

Check Out Our Latest Stock Report on Kewaunee Scientific

About Kewaunee Scientific

(Get Free Report)

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.

Featured Stories